theory clinical_23_9
imports Main

begin

typedecl entity
typedecl event

consts
  CTNNB1Mutation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  BetaCateninActivity :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Through :: "event ⇒ entity ⇒ bool"
  YAPInhibitor :: "entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Reduce :: "event ⇒ bool"
  Cause :: "event ⇒ entity ⇒ bool"
  Lead :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  EffectiveTreatment :: "event ⇒ entity ⇒ bool"
  Contribute :: "event ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote the proliferation of cells through the activity of β-catenin. *)
axiomatization where
  explanation_1: "∀x y z e. CTNNB1Mutation x ∧ Cell y ∧ BetaCateninActivity z ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Through e z"

(* Explanation 2: A YAP inhibitor can inhibit β-catenin activity. *)
axiomatization where
  explanation_2: "∃x y e. YAPInhibitor x ∧ BetaCateninActivity y ∧ Inhibit e ∧ Agent e x ∧ Patient e y"

(* Explanation 3: Inhibiting β-catenin activity reduces the proliferation of cells caused by activating mutations of CTNNB1. *)
axiomatization where
  explanation_3: "∀x y z e1 e2. BetaCateninActivity x ∧ Cell y ∧ CTNNB1Mutation z ∧ Inhibit e1 ∧ Agent e1 x ∧ Reduce e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Cause e2 z"

(* Explanation 4: A YAP inhibitor, by inhibiting β-catenin activity, reduces cell proliferation, which directly leads to the effective treatment of patients with activating CTNNB1 mutations. *)
axiomatization where
  explanation_4: "∃x y z w e1 e2 e3. YAPInhibitor x ∧ Cell y ∧ CTNNB1Mutation z ∧ BetaCateninActivity w ∧ Inhibit e1 ∧ Agent e1 x ∧ Patient e1 w ∧ Reduce e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Lead e3 ∧ Agent e3 y ∧ Directly e3 ∧ EffectiveTreatment e3 z"

(* Explanation 5: The reduction in cell proliferation caused by a YAP inhibitor's inhibition of β-catenin activity directly contributes to the effective treatment of patients with activating CTNNB1 mutations. *)
axiomatization where
  explanation_5: "∃x y z w e1 e2 e3. YAPInhibitor x ∧ Cell y ∧ CTNNB1Mutation z ∧ BetaCateninActivity w ∧ Inhibit e1 ∧ Agent e1 x ∧ Patient e1 w ∧ Reduce e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Contribute e3 ∧ Agent e3 y ∧ Directly e3 ∧ EffectiveTreatment e3 z"

theorem hypothesis:
  assumes asm: "YAPInhibitor x ∧ CTNNB1Mutation y"
  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations *)
  shows "∃x y. YAPInhibitor x ∧ CTNNB1Mutation y ⟶ (∃e. EffectiveTreatment e y)"
proof -
  (* From the premise, we have known information about YAP inhibitor and activating CTNNB1 mutations. *)
  from asm have "YAPInhibitor x ∧ CTNNB1Mutation y" by auto
  (* There is a derived implication Implies(D, E), which states that a YAP inhibitor implies effective treatment of patients with activating CTNNB1 mutations. *)
  (* Since we have YAPInhibitor x, we can infer the effective treatment. *)
  then have "∃e. EffectiveTreatment e y" sledgehammer
  then show ?thesis <ATP>
qed

end
